Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures.
about
The genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii NCC 533Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivariusCytokine-Induced Modulation of Colorectal CancerMechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont SelectionProbiotics for the treatment of Helicobacter pylori infection in childrenExploring alternative treatments for Helicobacter pylori infectionProbiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathologyModeling long-term host cell-Giardia lamblia interactions in an in vitro co-culture systemContributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip.Regulation of Intestinal Immune Responses through TLR Activation: Implications for Pro- and PrebioticsOxygen relieves the CO2 and acetate dependency of Lactobacillus johnsonii NCC 533Micropatterned co-cultures of T-lymphocytes and epithelial cells as a model of mucosal immune systemProbiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells.A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients.Immunomodulatory activity of two potential probiotic strains in LPS-stimulated HT-29 cellsImmunobiotic Lactobacillus rhamnosus strains differentially modulate antiviral immune response in porcine intestinal epithelial and antigen presenting cells.Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice.Host specific diversity in Lactobacillus johnsonii as evidenced by a major chromosomal inversion and phage resistance mechanismsTargeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics eraDetection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis.Enteric flora in health and disease.Induction by a lactic acid bacterium of a population of CD4(+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10.Probiotics and prebiotics in chronic inflammatory bowel diseases.Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic bacteria: involvement of toll-like receptors.An important role of interleukin-10 in counteracting excessive immune response in HT-29 cells exposed to Clostridium butyricum.Safety and protective effectiveness of two strains of Lactobacillus with probiotic features in an experimental model of salmonellosisDivergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro.The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiotaPolyunsaturated fatty acids modify expression of TGF-β in a co-culture model ultilising human colorectal cells and human peripheral blood mononuclear cells exposed to Lactobacillus gasseri, Escherichia coli and Staphylococcus aureus.Administration of probiotics influences F4 (K88)-positive enterotoxigenic Escherichia coli attachment and intestinal cytokine expression in weaned pigsModel organism proteomics as a tool for the study of host-microbiome interactions.The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept)Salmonella adhesion, invasion and cellular immune responses are differentially affected by iron concentrations in a combined in vitro gut fermentation-cell model.Symbiosis, dysbiosis, and rebiosis-the value of metaproteomics in human microbiome monitoring.Modulation of Intestinal Epithelial Defense Responses by Probiotic Bacteria.Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria.Bacterial secretions of nonpathogenic Escherichia coli elicit inflammatory pathways: a closer investigation of interkingdom signaling.Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.Probiotics and the management of inflammatory bowel disease.
P2860
Q22066391-CC2E3234-8BBC-4731-A123-6CC05C31983CQ24682955-F66292B5-E29C-4DC5-9579-F654CF7907DCQ26752374-84912F1D-5DD7-4964-ACDE-6703980D500EQ26774688-8E73DDEA-B296-4FF9-9A25-1FDD8366ABF8Q26825005-D930B0DA-82A5-4B6F-9EA4-48A0975E8EACQ26828017-8265DEAE-CF6D-4C4E-BB46-E86D09643A9BQ27027791-E3407154-2E9B-4840-9610-3BA6721124B1Q27301395-0C688004-8237-485D-9D62-0D15A67EAB53Q27316911-49C50741-1076-48DC-9148-9D2BEC3552E1Q28235354-457C4D3A-4550-4D30-9DB4-220AE7A49ECBQ28486844-1A6F9D6C-88D1-4DED-84F0-3AAC9BF2C0F5Q33418044-1ED6F2DC-5059-4872-9693-640077766309Q33554139-A5BC3991-D7C4-4D3F-A76D-09F59C214E77Q33590786-552A4860-4A1C-4143-BF06-D025F3E12FAFQ33632901-EA105CA4-96D7-4D0E-A4E2-6F6F1034D530Q33673989-A8E87A1B-C5F3-4B5D-86D5-8E6168CF8986Q33795727-8A4793E9-36F3-44DA-A23B-14C41423575AQ33886266-40622028-C285-4861-B798-267E919AE0BFQ33939802-7F6751FA-7B39-43DF-8285-C298BCF6A905Q33989634-B4D08E40-2852-4D70-A29E-A20F0A0C98C3Q33993768-B91EA9E4-B7BD-460E-9641-9D038FB32981Q33999211-480324B9-0D15-4851-93F6-3D80848BCAE2Q34013030-C8C79F35-30E6-4C36-9D12-1603400BC083Q34025073-64A6B9F1-9F3A-4EDE-8F5C-4637678D677FQ34045470-917C15C5-500C-41DD-ABD8-A441D6498948Q34297879-19CAEC13-FF1F-46AF-A316-5B38211103B4Q34348003-CD50DF57-504F-4E89-9A5B-A83FD97D3CF9Q34522706-D7C5180C-083D-4106-B43F-F672252C9095Q34647328-C2D3113A-AD8B-4879-8F33-959F7C10EB90Q34802933-AD00DDA2-F2D6-4753-BA10-A9A0951743C2Q35074005-4050AA70-8D81-4639-A169-19E3017B77ACQ35109893-92E7A1E4-F79A-499B-A9BD-5A13D5F28040Q35132150-D6F9224C-6332-4542-B1FA-C8201FA24287Q35133715-948F75AD-6C96-4113-92BF-E28331302E04Q35328312-8F5238B4-A1DF-450D-9D1C-F181B816571DQ35550764-01E059CF-2F17-4E98-9D20-5FA194646CD4Q35595154-B15C4DB8-56FC-438F-97EE-D6F771E755DAQ35677449-2700DA16-29AC-4CCF-B401-F437416D73FAQ35760489-73531324-9D5E-4FF2-B70A-D836738613D3Q35854517-79AEA3DF-B45C-459D-98D9-1DA0D1A429E4
P2860
Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Non-pathogenic bacteria elicit ...... al cell/leucocyte co-cultures.
@en
Non-pathogenic bacteria elicit ...... al cell/leucocyte co-cultures.
@nl
type
label
Non-pathogenic bacteria elicit ...... al cell/leucocyte co-cultures.
@en
Non-pathogenic bacteria elicit ...... al cell/leucocyte co-cultures.
@nl
prefLabel
Non-pathogenic bacteria elicit ...... al cell/leucocyte co-cultures.
@en
Non-pathogenic bacteria elicit ...... al cell/leucocyte co-cultures.
@nl
P2093
P2860
P356
P1433
P1476
Non-pathogenic bacteria elicit ...... al cell/leucocyte co-cultures.
@en
P2093
P2860
P356
10.1136/GUT.47.1.79
P407
P50
P577
2000-07-01T00:00:00Z